Francisella tularensis vaccines

FEMS Immunology and Medical Microbiology

Volumn 49, Issue 3, 2007, Pages 315-323

  Griffin, Kate F ^a   Oyston, Petra C F ^a   Titball, Richard W ^a,b  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Francisella tularensis; Tularaemia; Vaccine

Indexed keywords

BACTERIAL VACCINE; FRANCISELLA TULARENSIS VACCINE; INACTIVATED VACCINE; LIVE VACCINE; SUBUNIT VACCINE; UNCLASSIFIED DRUG;

AIRBORNE INFECTION; BACTERIAL STRAIN; BIOLOGICAL WARFARE; DRUG MECHANISM; FRANCISELLA TULARENSIS; HUMAN; MUTANT; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; TULAREMIA; VIRULENCE; VOLUNTEER;

BACTERIAL VACCINES; FRANCISELLA TULARENSIS; HUMANS; TULAREMIA; VACCINES, ATTENUATED; VACCINES, SUBUNIT;

EID: 33947206698     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2007.00219.x     Document Type: Short Survey

References (73)

1. Allen W (1962) Immunity against tularemia: passive protection of mice by transfer of immune tissues. J Exp Med 115: 411-420.
2. Anthony LSD, Gu M, Cowley SC, Leung WWS & Nano FE (1991) Transformation and allelic replacement in Francisella spp. J Gen Microbiol 137: 2697-2703.
3. Baron GS, Myltseva SV & Nano FE (1995) Electroporation of Francisella tularensis. Methods in Molecular Biology: Electroporation Protocols for Microorganisms, Vol. 47 (Nickoloff JA, ed), pp. 149-154. Humana Press Inc., New Jersey.
4. Bakshi CS, Malik M, Regan K, Melendez JA, Metzger DW, Pavlov VM & Sellati TJ (2006) Superoxide dismutase B gene (sodB)-deficient mutants of Francisella tularensis demonstrate hypersensitivity to oxidative stress and attenuated virulence. J Bacteriol 188: 6443-6448.
5. Burke DS (1977) Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory acquired tularemia. J Infect Dis 135: 55-60.
6. Casadevall A (1998) Antibody-mediated protection against intracellular pathogens. Trends Microbiol 6: 102-107.
7. Casadevall A & Pirofski LA (2003) Antibody-mediated regulation of cellular immunity and the inflammatory response. Trends Immunol 24: 474-478.
8. Clemens DL, Lee BY & Horwitz MA (2004) Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages. Infect Immun 72: 3204-3217.
9. Clemens DL, Lee BY & Horwitz MA (2005) Francisella tularensis enters macrophages via a novel process involving pseudopod loops. Infect Immun 73: 5892-5902.
10. Conlan JW & North RJ (1992) Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes. Infect Immun 60: 5164-5171.
11. Conlan JW, Sjostedt A & North RJ (1994) CD4+ and CD8+ T-cell-dependent and -independent host defence mechanisms can operate to control and resolve primary and secondary Francisella tularensis LVS infection in mice. Infect Immun 62: 5603-5607.
12. Conlan JW, Shen H, Webb A & Perry MB (2002) Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen. Vaccine 20: 3465-3471.
13. Coriell LL, King EO & Smith MG (1948) Studies on tularemia IV. Observations on tularemia in control and vaccinated monkeys. J Immunol 58: 183-202.
14. Deng K, Blick RJ, Liu W & Hansen EJ (2006) Identification of Francisella tularensis genes affected by iron limitation. Infect Immun 74: 4224-4236.
15. Dennis DT, Inglesby TV, Henderson DA et al. (2001) Tularemia as a biological weapon - medical and public health management. JAMA 285: 2763-2773.
16. Drabick JJ, Narayanan RB, Williams JC, Leduc JW & Nacy CA (1994) Passive protection of mice against lethal Francisella tularensis (Live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine. Am J Med Sci 308: 83-87.
17. Elkins KL, Cowley SC & Bosio CM (2003) Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain. Microbe Infect 5: 135-142.
18. Ellis J, Oyston PCF, Green M & Titball RW(2002) Tularemia. Clin Microbiol Rev 15: 631-646.
19. Essex-Lopresti AE, Boddey JA, Thomas R et al. (2005) A type IV pilin, PilA, contributes to adherence of Burkholderia pseudomallei and virulence in vivo. Infect Immun 73: 1260-1264.
20. Forestal CA, Benach JL, Carbonara C, Italo JK, Lisinski TJ & Furie MB (2003) Francisella tularensis selectively induces proinflammatory changes in endothelial cells. J Immunol 171: 2563-2570.
21. Forslund AL, Kuoppa K, Svensson K et al. (2006) Direct repeat-mediated deletion of a type IV pilin gene results in major virulence attenuation of Francisella tularensis. Mol Microbiol 59: 1818-1830.
22. Fortier AH, Leiby DA, Narayanan RB, Asafoadjei E, Crawford RM, Nacy CA & Meltzer MS (1995) Growth of Francisella tularensis LVS in macrophages: the acidic intracellular compartment provides essential iron required for growth. Infect Immun 63: 1478-1483.
23. Foshay L (1950) Tularemia. Ann Rev Microbiol 4: 313-330.
24. Foshay L, Hesselbrock WH, Wittenberg HJ & Rodenberg AH (1942) Vaccine prophylaxis against tularemia in man. Am J Public Health 32: 1131-1145.
25. Fuller CL, Brittingham KC, Hepburn MJ, Martin JW, Petitt PL, Pittman PR & Bavari S (2006) Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination. J Allergy Clin Immunol 117: 1186-1188.
26. Fulop M, Manchee R & Titball R (1995) Role of lipopolysaccharide and a major outer-membrane protein from Francisella tularensis in the induction of immunity against tularemia. Vaccine 13: 1220-1225.
27. Fulop M, Mastroeni P, Green M & Titball RW (2001) Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis. Vaccine 19: 4465-4472.
28. Gil H, Platz GJ, Forestal CA, Monfett M, Bakshi CS, Sellati TJ, Furie MB, Benach JL & Thanassi DG (2006) Deletion of TolC orthologs in Francisella tularensis identifies roles in multidrug resistance and virulence. Proc Natl Acad Sci USA 103: 12897-12902.
29. Gill V & Cunha BA (1997) Tularemia pneumonia. Sem Resp Infect 12: 61-67.
30. Golovliov I, Ericsson M, Akerblom L, Sandstrom G, Tarnvik A & Sjostedt A (1995) Adjuvanticity of iscoms incorporating a T-cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis. Vaccine 13: 261-267.
31. Golovliov I, Ericsson M, Sandstrom G, Tarnvik A & Sjostedt A (1997) Identification of proteins of Francisella tularensis induced during growth in macrophages and cloning of the gene encoding a prominently induced 23-kilodalton protein. Infect Immun 65: 2183-2189.
32. Golovliov I, Baranov V, Krocova Z, Kovarova H & Sjostedt A (2003a) An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells. Infect Immun 71: 5940-5950.
33. Golovliov I, Sjostedt A, Mokrievich AN & Pavlov VM (2003b) A method for allelic replacement in Francisella tularensis. FEMS Microbiol Letts 222: 273-280.
34. Gordon M, Donaldson DM & Wright GG (1964) Immunization of mice with irradiated Pasteurella tularensis. J Infect Dis 114: 435-440.
35. Gosselin EJ, Gosselin DR & Lotz SA (2005) Natural killer and CD8 T cells dominate the response by human peripheral blood mononuclear cells to inactivated Francisella tularensis live vaccine strain. Hum Immunol 66: 1039-1049.
36. Gray CG, Cowley SC, Cheung KKM & Nano FE (2002) The identification of five genetic loci of Francisella novicida associated with intracellular growth. FEMS Microbiol Letts 215: 53-56.
37. Gurycova D (1998) First isolation of Francisella tularensis subsp. tularensis in Europe. Eur J Epidemiol 14: 797-802.
38. Hartley MG, Green M, Choules G, Rogers D, Rees DG, Newstead S, Sjostedt A & Titball RW (2004) Protection afforded by heat shock protein 60 from Francisella tularensis is due to copurified lipopolysaccharide. Infect Immun 72: 4109-4113.
39. Havlasová J, Hernychová L, Brychta M et al. (2005) Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia. Proteomics 5: 2090-2103.
40. Kadull PJ, Reames HR, Coriell LL & Foshay L (1950) Studies on tularemia. V. Immunisation of man. J Immunol 65: 425-435.
41. Kawula TH, Hall JD, Fuller JR & Craven RR (2004) Use of transposon-transposase complexes to create stable insertion mutant strains of Francisella tularensis LVS. Appl Env Microbiol 70: 6901-6904.
42. Kuoppa K, Forsberg A & Norqvist A (2001) Construction of a reporter plasmid for screening in vivo promoter activity in Francisella tularensis. FEMS Microbiol Letts 205: 77-81.
43. Kwaik YA (1998) Fatal attraction of mammalian cells to Legionella pneumophila. Mol Microbiol 30: 689-695.
44. Lai X-H & Sjostedt A (2003) Delineation of the molecular mechanisms of Francisella tularensis-induced apoptosis in murine macrophages. Infect Immun 71: 4642-4646.
45. Lai XH, Golovliov I & Sjostedt A (2001) Francisella tularensis induces cytopathogenicity and apoptosis in murine macrophages via a mechanism that requires intracellular bacterial multiplication. Infect Immun 69: 4691-4694.
46. Lai XH, Golovliov I & Sjostedt A (2004) Expression of IglC is necessary for intracellular growth and induction of apoptosis in murine macrophages by Francisella tularensis. Microb Pathog 37: 225-230.
47. Larsson PP, Oyston CF, Chain P et al. (2005) The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nature Genet 37: 153-159.
48. Lauriano CM, Barker JR, Nano FE, Arulanandarn BP & Klose KE (2003) Allelic exchange in Francisella tularensis using PCR products. FEMS Microbiol Letts 229: 195-202.
49. Lauriano CM, Barker JR, Yoon SS, Nano FE, Arulanandam BP, Hassettt DJ & Klose KE (2004) MglA regulates transcription of virulence factors necessary for Francisella tularensis intraamoebae and intramacrophage survival. Proc Natl Acad Sci USA 101: 4246-4249.
50. Lindgren H, Golovliov I, Baranov V, Ernst RK, Telepnev M & Sjostedt A (2004) Factors affecting the escape of Francisella tularensis from the phagolysosome. J Med Microbiol 53: 953-958.
51. Maier TM, Pechous R, Casey M, Zahrt TC & Frank DW(2006) In vivo Himar1-based transposon mutagenesis of Francisella tularensis. Appl Env Microbiol 72: 1878-1885.
52. Mangold T & Goldberg J (1999) Plague Wars: ATrue Story of Biological Warfare. Macmillan, London.
53. McCaffrey RL & Allen LA (2006) Pivotal advance: Francisella tularensis LVS evades killing by human neutrophils via inhibition of the respiratory burst and phagosome escape. J Leukoc Biol 80: 1224-1230.
54. McCrumb FR (1961) Aerosol infection of man with Pasteurella tularensis. Bacteriol Revs 25: 262-267.
55. Melillo A, Sledjesk iDD, Lipski S, Wooten RM, Basrur V & Lafontaine ER (2006) Identification of a Francisella tularensis LVS outer membrane protein that confers adherence to A549 human lung cells. FEMS Microbiol Lett 263: 102-108.
56. Norqvist A, Kuoppa K & Sandstrom G (1996) Construction of a shuttle vector for use in Francisella tularensis. FEMS Immunol Med Microbiol 13: 257-260.
57. Pammit MA, Raulie EK, Lauriano CM, Klose KE & Arulanandam BP (2006) Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia. Infect Immun 74: 2063-2071.
58. Pavlov VM, Mokrievich AN & Volkovoy K (1996) Cryptic plasmid pFNL10 from Francisella novicida-like F6168: the base of plasmid vectors for Francisella tularensis. FEMS Immunol Med Microbiol 13: 253-256.
59. Pechous R, Celli J, Penoske R, Hayes SF, Frank DW & Zahrt TC (2006) Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain. Infect Immun 74: 4452-4461.
60. Rusnak JM, Kortepeter MG, Hawley RJ, Anderson AO, Boudreau E & Eitzen E (2004) Rick of occupationally acquired illness from biological threat agents in unvaccinated laboratory workers. Biosec Bioterror Biodef Strat Prac Sci 2: 1-13.
61. Sandstrom G, Tarnvik A & Wolf-watz H (1987) Immunospecific T-lymphocyte stimulation by membrane proteins from Francisella tularensis. J Clin Microbiol 25: 641-644.
62. Santic M, Molmeret M & Abu Kwaik Y (2005) Modulation of biogenesis of the Francisella tularensis subsp novicida-containing phagosome in quiescent human macrophages and its maturation into a phagolysosome upon activation by IFN-gamma. Cell Microbiol 7: 957-967.
63. Shen H, Chen W & Conlan JW (2004) Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis. Microb Pathog 37: 107-110.
64. Sjostedt A, Sandstrom G & Tarnvik A (1990) Several membrane polypeptides of the live vaccine strain Francisella tularensis LVS stimulate T cells from naturally infected individuals. J Clin Microbiol 28: 43-48.
65. Stenmark S, Lindgren H, Tarnvik A & Sjostedt A (2003) Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica. Microb Pathog 35: 73-80.
66. Sullivan JT, Jeffery EF, Shannon JD & Ramakrishnan G (2006) Characterization of the siderophore of Francisella tularensis and role of fslA in siderophore production. J Bacteriol 188: 3785-3795.
67. Surcel HM, Sarvas M, Helander IM & Herva E (1989) Membrane proteins of Franceisella tularensis LVS differ in ability to induce proliferation of lymphocytes from tularemia-vaccinated individuals. 7: 411-419.
68. Tarnvik A (1989) Nature of protective immunity to Francisella tularensis. Revs Infect Dis 11: 440-451.
69. Tarnvik A & Lofgren S (1975) Stimulation of human lymphocytes by a vaccine strain of Francisella tularensis. Infect Immun 12: 951-957.
70. Tempel R, Lai XH, Crosa L, Kozlowicz B & Heffron F (2006) Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge. Infect Immun 74: 5095-5105.
71. Twine S, Bystrom M, Chen WX et al. (2005) A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine. Infect Immun 73: 8345-8352.
72. Wu TH, Hutt JA, Garrison KA, Berliba LS, Zhou Y & Lyons CR (2005) Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A. Infect Immun 73: 2644-2654.
73. Yee D, Rhinehart-Jones TR & Elkins KL (1996) Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J Immunol 157: 5042-5048.